Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease

American Journal of Hematology

Volumn 90, Issue 8, 2015, Pages 691-695

  Desai, Payal C ^a   Deal, Allison M ^b   Pfaff, Emily R ^b   Qaqish, Bahjat ^b   Hebden, Leyna M ^c   Park, Yara A ^d   Ataga, Kenneth I ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; BLOOD TRANSFUSION; CHILD; ECHOCARDIOGRAPHY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; FEMALE; HAZARD RATIO; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; VEIN OCCLUSION; AGE; ANEMIA, SICKLE CELL; AUTOIMMUNITY; BIOSYNTHESIS; BLOOD GROUP INCOMPATIBILITY; CELL AGING; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TRICUSPID VALVE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANEMIA, SICKLE CELL; AUTOIMMUNITY; BLOOD GROUP INCOMPATIBILITY; CELL AGING; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFANT; ISOANTIBODIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TRICUSPID VALVE;

EID: 84937516742     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24051     Document Type: Article

References (35)

1. Danielson CFM. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002;6:24-31.
2. Davies SC, Luce PJ, Win AA, et al. Acute chest syndrome in sickle-cell disease. Lancet 1984;1:36-38.
3. Hoppe C, Adams R, Vichinsky E. Transfusion therapy in sickle cell disease. Renaissance Sickle Cell Dis Res Genome Era 2007;117.
4. Morrison JC, Schneider JM, Whybrew WD, et al. Prophylactic transfusions in pregnant patients with sickle hemoglobinopathies: Benefit versus risk. Obstet Gynecol 1980;56:274
5. Piomelli S. Chronic transfusions in patients with sickle cell disease. Indications and problems. Am J Pediatr Hematol Oncol 1985;7:51
6. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990;76:1431
7. Orlina AR, Unger PJ, Koshy M. Post transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978;5:101-106.
8. Olujohungbe A, Hambleton I, Stephens L, et al. Red cell antibodies in patients with homozygous sickle cell disease: A comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661-665.
9. Vichinsky E. Consensus document for transfusion-related iron overload. Semin Hematol 2001;38:2-4.
10. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-1621.
11. Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062-1071.
12. Bauer MP, Wiersum Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007;47:2066-2071.
13. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006;46:1526-1536.
14. Schonewille H, Van De Watering LMG, Loomans DSE, et al. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006;46:250-256.
15. Zimring JC, Hendrickson JE. The role of inflammation in alloimmunization to antigens on transfused red blood cells. Curr Opin Hematol 2008;15:631
16. Bourantas KL, Dalekos GN, Makis A, et al. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol 1998;61:49-54.
17. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) 2005;230:68-74.
18. Jison ML, Munson PJ, Barb JJ, et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 2004;104:270-280.
19. Pathare A, Al Kindi S, Alnaqdy AA, et al. Cytokine profile of sickle cell disease in Oman. Am J Hematol 2004;77:323-328.
20. Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Invest 2000;106:337-338.
21. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management. Blood 2012;120:528-537.
22. Hendrickson JE, Hod EA, Spitalnik SL, et al. Immunohematology: Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion50:642-648.
23. Bao W, Zhong H, Li X, et al. Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol 2011;86:1001-1006.
24. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management. Blood 2012;120:528-537.
25. Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 115:4284-4292.
26. Xiong Z, Cavaretta J, Qu L, et al. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 51:610-621.
27. Donadee C, Raat NJH, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and Cell-free hemoglobin as a mechanism for the red cell storage lesion/clinical perspective. Circulation 124:465-476.
28. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
29. Locatelli F, Kabbara N, Ruggeri A, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013;122:1072-1078.
30. Aubron C, Nichol A, Cooper DJ, et al. Age of red blood cells and transfusion in critically ill patients. Ann Intensive Care 2013;3:2.
31. Pettila V, Westbrook A, Nichol A, et al. Age of red blood cells and mortality in the critically ill. Crit Care 2011;15:R116.
32. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94:1555-1560.
33. Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 1991;77:214-237.
34. Bean CJ, Boulet SL, Ellingsen D, et al. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 2012;120:3822-3828.
35. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996;88:2311-2320.